MedPath

carnitine in patients with MS

Not Applicable
Recruiting
Conditions
Fatigue in patients with Relapsing-remitting MS.
Multiple sclerosis
Registration Number
IRCT20211031052928N1
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
112
Inclusion Criteria

Patients with RRMS
FSS>4 or MFIS>38
EDSS=3.5

Exclusion Criteria

EDSS=4
Depression
Hypothyroidism
Patients receiving medicines like Antipsychotics, MAOi, Benzodiazepines, TCAs, Anti-seizures and Barbiturates
Severe kidney disfunction with GFR<30 ml/min

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fatigue. Timepoint: fatigue will be evaluated based on MFIS and FSS score before intervention and 2 months after. Method of measurement: Fatigue severity scale (FSS) and Modified fatigue impact scale (MFIS) Questionnaires.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath